લાઇવ Monday, 12 October 2026
બ્રેકિંગ
બિઝનેસ અને બજાર

ડીલ મંજૂર: CCI એ બેઇન કેપિટલ ફંડ્સના વિટાબાયોટિક્સના માલિકના નિયંત્રણને મંજૂરી આપી

કોમ્પિટિશન કમિશને આ સોદાને મંજૂરી આપી દીધી છે. મેયર ઓર્ગેનિક્સ ભારતમાં કેટલીક ઓવર-ધ-કાઉન્ટર અને પ્રિસ્ક્રિપ્શન ફાર્માસ્યુટિકલ્સ પણ બનાવે છે.
Deal cleared: CCI approves Bain Capital funds' control of Vitabiotics owner
પ્રતીકાત્મક તસવીર
  • Competition Commission of India has cleared sole control of Omega-Meyer Limited and Meyer Organics.
  • Two Bain Capital-linked funds will take control: BCPE Wellbeing Holdco Two and Integral Investments Asia IV.
  • Omega-Meyer controls the Vitabiotics group of companies and affiliates.
  • Targets make nutraceuticals globally and in India.
  • Meyer Organics also produces some OTC and prescription pharmaceuticals in India.

The Competition Commission of India has cleared a deal giving funds linked to Bain Capital sole control of Omega-Meyer Limited and Meyer Organics Private Limited.

Who is taking control

The buyers are BCPE Wellbeing Holdco Two Limited and Integral Investments Asia IV Limited. Both are investment vehicles managed or advised by Bain Capital.

Bain Capital is a private equity investment firm based in the USA. It puts money into companies across several industries.

Those sectors include information technology, healthcare, retail and consumer products, communications, financial services, and industrial and manufacturing.

What the companies do

Omega-Meyer Limited owns and controls a group of companies and affiliates trading as Vitabiotics. Meyer Organics Private Limited serves as the owner of the Meyer Organics business.

Both companies make nutraceuticals, sold globally as well as in India.

Meyer Organics also makes and supplies some over-the-counter and prescription finished-dose pharmaceuticals in India.

આ સમાચાર શેર કરો અને અમારી સાથે જોડાઓ: